Based on the overexpression of mitochondrial markers in IDH-wt glioblastomas undergoing oxidative stress, the study aims to evaluate the effect of metformin as an oral inhibitor of mitochondrial complex I, in combination with radiation and TMZ. This evidence concerns the gene IDH2 and glioblastoma.